Monoclonal antibody treatment combo can reduce the impact of COVID-19 in high-risk patients
In an observational study, Mayo Clinic researchers report that the combination of casirivimab and imdevimab – two monoclonal antibody treatments
Read more
In an observational study, Mayo Clinic researchers report that the combination of casirivimab and imdevimab – two monoclonal antibody treatments
Read more(Reuters) – The coronavirus variant first identified in Brazil, known as P.1, is resistant to three of the four antibody
Read moreThe treatment of relapsed or refractory follicular lymphoma (RRFL) is distinct from patients who are receiving treatment for the first
Read moreEye cancers are treated by a team of specialists and doctors. This is called a multidisciplinary team approach. The team
Read more